Should Pediatricians Refuse to Treat Patients Who Don’t Vaccinate?

186 views

Parents who don’t want to vaccinate their children are a perennial sore subject in my profession. The question bubbled up again this spring at the American Academy of Pediatrics’ Annual Leadership Forum, where academy leaders vote on issues of concern to pediatricians across the country…

Spotlight

Centene Corporation

Centene Corporation, a Fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored/hybrid programs, and Medicare. The Company operates local health plans and offers a range of health insurance solutions.

OTHER ARTICLES
HEALTH TECHNOLOGY

Components and Relevance of EHRs in Rural Hospitals

Article | December 8, 2022

Contents 1. Knowing The Basics 2. Importance Of EHR In A Rural Setting 3. Features That An EHR Must Have In A Rural Area Today, we will discuss the crucial featuresof electronic health records (EHR) in rural hospitals. However, before listing out the key components, let us first understand what EHR is and how it can help the smooth functioning of medical treatment in a rural setup. 1. Knowing the Basics! As the name suggests, an electronic health record is a computer file that stores a patient’s medical history, such as diagnosis, treatment, test results, etc. In short, an EHR is a digital version of a patient’s paper health record. It also includes previous appointments, billing details, and other general documentation. The need for an EHR popped up due to its easy and secure availability compared to patients' paper files. In addition, patients and doctors can easily access lab reports through an EHR that is updated in real-time and downloaded on any device with an internet connection. 2. Importance of EHR in a Rural Setting! Healthcare Information and Management Systems Society (HIMSS) defines EHR usability as “The effectiveness, efficiency, and satisfaction with which specific users can achieve a specific set of tasks in a particular environment.' In essence, a system with good usability is easy to use and effective. It is intuitive, forgiving of mistakes, and allows one to perform necessary tasks quickly, efficiently, and with a minimum of mental effort.” A patient's electronic health records can be beneficial in an era of digitization. It can improve patient care by minimizing the chances of medical errors, reducing test duplication, and making doctors and patients well-informed by fetching medical records anytime, thereby reducing delays in treatment. 3. Features That an EHR Must Have in a Rural Area EHRs can prove beneficial in all areas situated far off by accessing the real-time, up-to-date data of patients’ health records and making timely decisions. When the distance between the clinics and specialists is more, an EHR report can easily be sent to look into a patient’s history before delivering treatment. In a rural setup, EHR helps promote health awareness as patients' data can be monitored without needing to be physically present. Software-as-a-Service (SaaS) Solutions can be easily deployed in places with slow internet and help maintain a lightweight EHR that can support immediate patient care and easy documentation. Next comes the option of configuration over coding. At the Rural Health Clinic (RHC), an EHR that the local IT team can handle would be of more use than one that may require a specialist’s check or additional coding. An EHR, equipped with the ability to configure and customize as per the clinic’s workflow, will give more control to the RHCs and enable them to function efficiently. Another significant point of an EHR in a Rural Health Clinic will be the inclusion of applications that support instant communication, like Telehealth and patient portals. These applications enable direct consultation and virtual care of patients and specialists located far off, thereby reducing the dependency of RHCs on city or urban-based facilities. When we are discussing rural hospitals, we need to look for an application that is both affordable and functional, as rural areas mostly struggle with problems regarding budget and resources. Hence, keeping this in mind, RHCs should install a cloud-based EHR that does not require buying servers or employing IT staff. RHCs must use an EHR application with innovative analytic tools to access and develop reports for quick patient care decisions. In addition, the system must be able to pull large chunks of data and generate reports daily. Enjoyed reading this? Want to read more related articles? Click the link for more information! https://healthcare.report/trending-news/electronic-health-records-ehr-software-market-2019-foreseen-to-grow-exponentially-by-2026 Happy Reading!

Read More
HEALTH TECHNOLOGY, MEDICAL DEVICES

Role of AI and ML in the Healthcare Industry

Article | November 2, 2022

Contents 1. Alexa, Are You There? 2. Digital Assistants-Cum-Doctor-Assistants 3. Toward An AI-Friendly Life! 1. Alexa, Are You There? If Siri, Alexa, Google Now, or Cortana are your friends, you do not need any special introduction for today’s topic! This is because these digital assistants have become part and parcel of our lives; from completing our minimal tasks to helping us solve our problems, they make our day-to-day life simpler and more manageable. Popularly called AI, Artificial Intelligence is the simulation of human intelligence processes by machines. Similarly, Machine Learning, also called ML, is the capability of a machine to imitate intelligent human behavior. 2. Digital Assistants-cum-Doctor Assistants The unpredictable pandemic years, which took thousands of lives, depict the rise of complexities in the healthcare industry. To deal with such cases in the future tactfully, the healthcare segment needs to be proactive and implement advanced technologies to detect, resolve, and prevent untimely death. Modern technologies such as Artificial Intelligence and Machine Learning help the medical fraternity perform tasks usually done by humans quickly and accurately, saving much time that can be utilized elsewhere. Let’s take a quick tour of how AI and ML can boost the healthcare industry: Artificial Intelligence can broadly scan patient databases or consult patients via a chatbot or online support system to understand their symptoms, send data to doctors, and get real-time diagnoses and prescribed medicines. Machine Learning, a subset of AI, can replace traditional processes with a supervised one, as in, a patient can be treated based on similar symptoms and treatment of other patients. The process requires a quick scanning of the database, which can be time-consuming if done by human effort. Taking technology by storm, patients suffering from neurological disorders can be treated via Brain-Computer Interfaces (BCI) backed by AI. With the help of this technology, normal bodily functions, such as the ability to move, speak or react, can be restored. It can also assist doctors in treating patients with strokes, locked-in syndrome, etc.The healthcare segment is revolutionizing, as sensitive operations such as heart surgery are being performed with robotic precision and control with AI-based algorithms. For this purpose, precision machine learning processes are being used to train robots and improve accuracy. AI can also help in digital pathology. Instead of placing separate slides or tissue blocks and observing them manually, pathologists can do it via AI, which can help analyze digital slides using image analysis and machine learning. 3. Toward an AI-friendly Life! If you never forget to wear a smartwatch, track daily steps, get water intake notifications, eat mindfully, and consistently monitor pulse rates, then you are already AI-friendly! You have successfully incorporated AI into your life and taken the first step towarda healthy life!

Read More
HEALTH TECHNOLOGY

What are the Key Types of Healthcare Supply Chain Management Solutions?

Article | August 29, 2022

Introduction Within the last two years, the healthcare industry saw an influx in patient care as COVID-19 swept through communities across the globe. The widespread shortage of patient care tools, personal protective equipment (PPE), and medical technology amid the pandemic led to an exponential rise in health expenditures and demand for essential supplies. In response to the medical demand-supply imbalance, the governments of numerous countries increased their medical care expenditures to counter the challenges of patient care equipment shortages. For instance, according to the National Healthcare Expenditure Data, federal government spending on healthcare and medical care grew by 36% in 2020 and is estimated to reach US$ 6.2 trillion by 2028 in the U.S. Despite the rise in medical budget allocations, medical facilities are still facing difficulties obtaining enough supplies with the growing prevalence of numerous chronic, infectious, and hereditary diseases. As a result, organizations are focusing on deploying innovative solutions, such as healthcare supply chain management software, to keep track of inventory, procurement, logistics, and others and strengthen their supply chain. Healthcare Supply Chain Management Solutions: Key Types Healthcare systems, hospitals, and other patient care sites require a broad array of supplies to perform diagnosis and treatment, from masks and gloves to catheters and implants. Inadequate supplies coupled with inflation is making supply chain management a crucial but complex component in providing optimal patient care across the healthcare industry. This has shed more light on the role of supply chain management in saving lives. Effective supply chains help various regulatory agencies, including medical goods manufacturers and insurance companies, deliver essential supplies, resources, technologies, and other patient care goods to healthcare establishments. Supply chain management solutions are thus garnering massive traction among healthcare organizations for simplifying and automating manual supply chain and logistics operations. Let’s have a look at the types of supply chain management software that assist healthcare organizations to optimize their supply chain processes Inventory Management Software Efficient medical inventory management is critical for the running of healthcare organizations. The software provides real-time inventory tracking, assisting organizations in closely monitoring inventory changes, avoiding shortages of both low-value and high-use patient care items, decreasing the wait time for access to medical supplies, and reducing the chances of late delivery. Order Management Software It is crucial for healthcare establishments to have an estimate of the demand and supply of goods to prevent shortages. Order management software enables these organizations to coordinate supply chain demand planning and forecasting. It also assists in streamlining warehouse operations, resulting in faster and more accurate order placement. Sourcing and Procurement Software By tapping into the power of sourcing and procurement solutions, healthcare organizations can develop robust sourcing processes and automate, streamline, and optimize their entire procurement processes. The software also assists establishments in improving their supply inventory levels, identifying the best supplier, and reducing their overall purchasing cost. Shipping and Tracking Software Shipping and tracking software assist in the planning and execution of the physical movement of goods. These solutions are primarily used by medical equipment manufacturers and suppliers during the delivery or relocation of patient care goods. The integration of these solutions enables organizations to track and manage numerous batches of goods in transit. The Bottom Line Growing competition, healthcare regulations, shipping costs, and increased logistics requirements from medical institutions have complicated the supply chain management processes. As a result, life-science companies are investing in cutting-edge supply chain management solutions to reduce numerous errors, improve logistics, and eliminate unnecessary costs spent to fix them. Thus, several companies are now emphasizing the incorporation of cutting-edge technologies, including artificial intelligence and data analytics, into healthcare supply chain management software to reap benefits such as process automation, streamlined inventory, reduced waste, improved decision-making, and lower labor, supply, and operational costs.

Read More

3 Key Considerations in Cloud Security for Healthcare Organizations

Article | February 12, 2020

With medical system consolidation and increasing numbers of medical records created, the need for digital access and storage is gaining steam. Digitizing records allows clinicians to improve accuracy and decrease redundant testing and studies, as well as reduce treatment delays. Greater availability of digitized records has other perks too. With vast amounts of accessible medical data, researchers can move public health studies forward, also potentially improving care and treatment of individual patients. As a result, cloud storage is taking off, though healthcare organizations are adopting it more slowly than other industries. According to a 2019 Nutanix report, 71% of healthcare organizations using cloud were considered the least mature – relative beginners – in that they were using fewer cloud services. Compare that figure to finance or retail, where 13% and 15% respectively were beginners. However, that is changing.

Read More

Spotlight

Centene Corporation

Centene Corporation, a Fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored/hybrid programs, and Medicare. The Company operates local health plans and offers a range of health insurance solutions.

Related News

HEALTH TECHNOLOGY

Texas Children's Hospital And Baylor College of Medicine COVID-19 Vaccine Technology Secures Emergency Use Authorization In India

Texas Children Hospital | December 29, 2021

Texas Children's Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General ofIndia(DCGI)to launch inIndiawith other underserved countries to follow. Dubbed "The World's COVID-19 Vaccine", it uses a traditional recombinant protein-based technology that will enable its production at large scales making it widely accessible to inoculate the global population. The initial construct and production process of the vaccine antigen was developed at Texas Children's Hospital CVD, led by co-directors Drs. Maria Elena Bottazzi and Peter Hotez and in-licensed from BCM Ventures, Baylor College of Medicine's integrated commercialization team, to Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE). CORBEVAX™ after completing two Phase III clinical trials involving more than 3000 subjects was found to be safe, well tolerated and immunogenic: CORBEVAX™ demonstrated superior immune response in comparison with COVISHIELD™ vaccine when assessed for Neutralizing Antibody (nAb) Geometric Mean Titers (GMT) against the Ancestral-Wuhan strain and the globally dominant Delta variant. CORBEVAX™ vaccination also generated significant Th1 skewed cellular immune response. CORBEVAX™ nAb GMT against Ancestral-Wuhan strain is indicative of vaccine effectiveness of >90% for prevention of symptomatic infections based on the Correlates of Protection assessment performed during Moderna and Astra-Zeneca vaccine Phase III studies. CORBEVAX™ nAb GMT against the Delta strain indicates a vaccine effectiveness of >80 percent for the prevention of symptomatic infections based on published studies. While none of the subjects who took CORBEVAX™ or COVISHIELD™ had serious adverse events, CORBEVAX™ had 50 percent fewer adverse events than COVISHIELD™. In the continuous monitoring of phase II studies, CORBEVAX™ showed high persistence of immune response as indicated by <30% drop in nAb GMT till 6 months second dose as compared to >80% drop observed with majority of the vaccines. "Protein-based vaccines have been widely used to prevent many other diseases, have proven safety records, and use economies of scale to achieve low-cost scalability across the world," said Dr. Maria Elena Bottazzi, Professor and Associate Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children's Hospital Center for Vaccine Development. "Our decade-long studies advancing coronavirus vaccine prototypes has led to the creation of this vaccine, which will fill the access gap created by the more expensive, newer vaccine technologies and that today are still not able to be quickly scaled for global production." The need for safe, streamlined, low-cost vaccines for middle- to low-income countries is central to the world's fight against the COVID-19 pandemic. Without widespread vaccination of populations in the Global South, additional virus variants will arise, hindering the progress achieved by currently available vaccines in the United States and other Western countries. "This announcement is an important first step in vaccinating the world and halting the pandemic. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant," said Dr. Peter Hotez, Professor and Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children's Hospital Center for Vaccine Development. "Widespread and global vaccination with our Texas Children's-Baylor-BE vaccine would also forestall the emergence of new variants. We have previously missed that opportunity for the alpha and delta variant. Now is our chance to prevent a new global wave from what might follow." "Over the years, we have worked to make quality vaccines and pharmaceutical products accessible to families around the world. With this as our backdrop, we resolved to develop an affordable and effective COVID-19 vaccine. It has now become a reality. We deeply appreciate Texas Children's Hospital Center for Vaccine Development, Baylor, CEPI, the Bill and Melinda Gates Foundation, and the government of India for their continuous support and cooperation during this journey. The combined efforts & unceasing support demonstrate that we can collectively overcome any challenge". Mahima Datla, Managing Director, Biological E. Limited ABOUT TEXAS CHILDREN'S HOSPITAL Texas Children's Hospital, a not-for-profit health care organization, is committed to creating a healthier future for children and women throughout the global community by leading in patient care, education and research. Consistently ranked as the best children's hospital in Texas, and among the top in the nation, Texas Children's has garnered widespread recognition for its expertise and breakthroughs in pediatric and women's health. The hospital includes the Jan and Dan Duncan Neurological Research Institute; the Feigin Tower for pediatric research; Texas Children's Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; Texas Children's Hospital West Campus, a community hospital in suburban West Houston; and Texas Children's Hospital The Woodlands, the first hospital devoted to children's care for communities north of Houston. The organization also created Texas Children's HealthPlan, the nation's first HMO for children; has the largest pediatric primary care network in the country, Texas Children's Pediatrics; Texas Children's Urgent Care clinics that specialize in after-hours care tailored specifically for children; and a global health program that's channeling care to children and women all over the world. Texas Children's Global Health program leads efforts that advance health care equity through innovative collaboration in care, education and research for underserved populations globally. Texas Children's Hospital is affiliated with Baylor College of Medicine. ABOUT TEXAS CHILDREN'S HOSPITAL CENTER FOR VACCINE DEVELOPMENT Texas Children's Hospital Center for Vaccine Development is one of the leading vaccine development centers in the world. Established in Washington DC as the Sabin Vaccine Institute Product Development Partnership (PDP) in the year 2000 and after relocating to the Texas Medical Center in 2011, it rebranded as Texas Children's Center for Vaccine Development. For the past two decades it has acquired an international reputation as a non-profit PDP, advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. In addition, it builds and strengthens capacity for vaccine development locally and with foreign nations and leads global efforts to guide and influence vaccine policy and advocacy through "vaccine diplomacy" as an international bridge for peace and vaccine development capacity. ABOUT BCM VENTURES Baylor College of Medicine Ventures is the commercial engine of the health sciences university, created to support the translation of academic knowledge and intellectual assets for the benefit of society. We do this by engaging university innovators, entrepreneurs and industry to fully develop ideas along their best commercial path. We foster a culture of commercialization and engage with industry to identify market opportunities for collaborative ventures. ABOUT BIOLOGICAL E. LIMITED Biological E. Limited (BE), a Hyderabad-based Pharmaceuticals & Biologics Company founded in 1953, is the first private sector biological products company in India and the first pharmaceutical company in Southern India. BE develops, manufactures and supplies vaccines and therapeutics. BE supplies its vaccines to over 100 countries and its therapeutic products are sold in India and the USA. BE currently has 8 WHO-prequalified vaccines in its portfolio. In recent years, BE has embarked on new initiatives for organisational expansion such as developing generic injectable products for the regulated markets, exploring synthetic biology and metabolic engineering as a means to manufacture APIs sustainably and developing novel vaccines for the global market.

Read More

HEALTH TECHNOLOGY

Nemours Children's Health Chooses the Innovaccer Health Cloud to Support Value-Based Whole-Person Care

Innovaccer Inc. | October 13, 2021

Today Innovaccer Inc., the Health Cloud company, announced a partnership with Nemours Children's Health, one of the nation's largest clinically integrated pediatric health systems, to create a unified data platform designed to accelerate Nemours' mission to transform children's health through a holistic care model. The partnership will integrate and activate clinical and claims data from across the health system to enable intelligent point-of-care analytics that can help identify and close care gaps, optimize management of at-risk lives, and improve clinical outcomes for pediatric patients. Nemours' clinically integrated network (CIN), Delaware Children's Health Network, will leverage the InnovaccerⓇ Health Cloud for clinical and financial insights for 50K+ patients in their network. The Health Cloud's advanced analytics can then use this unified patient data to generate clinical and business insights that support effective cost, utilization, and risk management across the CIN, and across multiple provider and payer contracts. Customizable dashboards will allow the CIN leadership to drill into and understand cost, utilization, risk trends; and digitally transform population risk stratification and health management techniques to identify and address specific population management challenges, match risk with levels of care, individualize treatment plans to lower risk and improve function, and ensure alignment with value-based care models. Indeed, as Nemours Children's Health enters its value-based full-risk contracts they will be using the Innovaccer Health Cloud's intrinsic interoperability and data activation capabilities to integrate payer feeds from both Medicaid and Commercial payers in both the Delaware Valley and Florida—ensuring a 360° actionable view of clinical and financial information. "Our goal is simple—to redefine children's health by helping our communities and families ensure the healthiest futures for our children. By bringing the full richness of our children's healthcare data together, we can better see and understand 'the big picture,' and address all of the factors that influence a child's health. This partnership will help us continue to deliver the safe, high-quality, whole-person care every child deserves." Jonathan Miller, Medical Director for the Nemours Value Based Services Organization About Nemours Children's Health Nemours Children's Health is one of the nation's largest multistate pediatric health systems, including two free-standing children's hospitals and a network of nearly 80 primary and specialty care practices across five states. Nemours mission is "to provide leadership, institutions, and services to restore and improve the health of children through care and programs not readily available, with one high standard of quality and distinction, regardless of the recipient's financial status." Nemours seeks to transform the health of children by adopting a holistic health model that utilizes innovative, safe, and high-quality care, while also caring for the health of the whole child beyond medicine. Nemours also powers the world's most-visited website for information on the health of children and teens, KidsHealth.org. The Nemours Foundation, established through the legacy and philanthropy of Alfred I. duPont, provides pediatric clinical care, research, education, advocacy and prevention programs to the children, families and communities it serves. About Innovaccer Innovaccer Inc., the Health Cloud company, is a leading San Francisco-based healthcare technology company committed to helping healthcare care as one. The Innovaccer Health Cloud unifies patient data across systems and settings, and empowers healthcare organizations to rapidly develop scalable, modern applications that improve clinical, operational, and financial outcomes. Innovaccer's solutions have been deployed across more than 1,000 care settings in the U.S., enabling more than 37,000 providers to transform care delivery and work collaboratively with payers and life sciences companies. Innovaccer has helped organizations integrate medical records for more than 24 million people and generate more than $600 million in savings. Innovaccer is recognized as a Best in KLAS vendor for 2021 in population health management and is the #1 customer-rated vendor by Black Book.

Read More

First rapid detection Zika test now available through collaboration with Texas Children’s Hospital and Houston Methodist Hospital

Texas Children's Hospital | February 23, 2016

Collaboration between two Texas Medical Center institutions has resulted in today’s release of the country’s first hospital-based rapid tests for the Zika virus.Pathologists and clinical laboratory scientists at Texas Children’s Hospital and Houston Methodist Hospital developed the Zika direct test in a matter of weeks as part of the L.E. and Virginia Simmons Collaborative in Virus Detection and Surveillance.

Read More

HEALTH TECHNOLOGY

Texas Children's Hospital And Baylor College of Medicine COVID-19 Vaccine Technology Secures Emergency Use Authorization In India

Texas Children Hospital | December 29, 2021

Texas Children's Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General ofIndia(DCGI)to launch inIndiawith other underserved countries to follow. Dubbed "The World's COVID-19 Vaccine", it uses a traditional recombinant protein-based technology that will enable its production at large scales making it widely accessible to inoculate the global population. The initial construct and production process of the vaccine antigen was developed at Texas Children's Hospital CVD, led by co-directors Drs. Maria Elena Bottazzi and Peter Hotez and in-licensed from BCM Ventures, Baylor College of Medicine's integrated commercialization team, to Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE). CORBEVAX™ after completing two Phase III clinical trials involving more than 3000 subjects was found to be safe, well tolerated and immunogenic: CORBEVAX™ demonstrated superior immune response in comparison with COVISHIELD™ vaccine when assessed for Neutralizing Antibody (nAb) Geometric Mean Titers (GMT) against the Ancestral-Wuhan strain and the globally dominant Delta variant. CORBEVAX™ vaccination also generated significant Th1 skewed cellular immune response. CORBEVAX™ nAb GMT against Ancestral-Wuhan strain is indicative of vaccine effectiveness of >90% for prevention of symptomatic infections based on the Correlates of Protection assessment performed during Moderna and Astra-Zeneca vaccine Phase III studies. CORBEVAX™ nAb GMT against the Delta strain indicates a vaccine effectiveness of >80 percent for the prevention of symptomatic infections based on published studies. While none of the subjects who took CORBEVAX™ or COVISHIELD™ had serious adverse events, CORBEVAX™ had 50 percent fewer adverse events than COVISHIELD™. In the continuous monitoring of phase II studies, CORBEVAX™ showed high persistence of immune response as indicated by <30% drop in nAb GMT till 6 months second dose as compared to >80% drop observed with majority of the vaccines. "Protein-based vaccines have been widely used to prevent many other diseases, have proven safety records, and use economies of scale to achieve low-cost scalability across the world," said Dr. Maria Elena Bottazzi, Professor and Associate Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children's Hospital Center for Vaccine Development. "Our decade-long studies advancing coronavirus vaccine prototypes has led to the creation of this vaccine, which will fill the access gap created by the more expensive, newer vaccine technologies and that today are still not able to be quickly scaled for global production." The need for safe, streamlined, low-cost vaccines for middle- to low-income countries is central to the world's fight against the COVID-19 pandemic. Without widespread vaccination of populations in the Global South, additional virus variants will arise, hindering the progress achieved by currently available vaccines in the United States and other Western countries. "This announcement is an important first step in vaccinating the world and halting the pandemic. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant," said Dr. Peter Hotez, Professor and Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children's Hospital Center for Vaccine Development. "Widespread and global vaccination with our Texas Children's-Baylor-BE vaccine would also forestall the emergence of new variants. We have previously missed that opportunity for the alpha and delta variant. Now is our chance to prevent a new global wave from what might follow." "Over the years, we have worked to make quality vaccines and pharmaceutical products accessible to families around the world. With this as our backdrop, we resolved to develop an affordable and effective COVID-19 vaccine. It has now become a reality. We deeply appreciate Texas Children's Hospital Center for Vaccine Development, Baylor, CEPI, the Bill and Melinda Gates Foundation, and the government of India for their continuous support and cooperation during this journey. The combined efforts & unceasing support demonstrate that we can collectively overcome any challenge". Mahima Datla, Managing Director, Biological E. Limited ABOUT TEXAS CHILDREN'S HOSPITAL Texas Children's Hospital, a not-for-profit health care organization, is committed to creating a healthier future for children and women throughout the global community by leading in patient care, education and research. Consistently ranked as the best children's hospital in Texas, and among the top in the nation, Texas Children's has garnered widespread recognition for its expertise and breakthroughs in pediatric and women's health. The hospital includes the Jan and Dan Duncan Neurological Research Institute; the Feigin Tower for pediatric research; Texas Children's Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; Texas Children's Hospital West Campus, a community hospital in suburban West Houston; and Texas Children's Hospital The Woodlands, the first hospital devoted to children's care for communities north of Houston. The organization also created Texas Children's HealthPlan, the nation's first HMO for children; has the largest pediatric primary care network in the country, Texas Children's Pediatrics; Texas Children's Urgent Care clinics that specialize in after-hours care tailored specifically for children; and a global health program that's channeling care to children and women all over the world. Texas Children's Global Health program leads efforts that advance health care equity through innovative collaboration in care, education and research for underserved populations globally. Texas Children's Hospital is affiliated with Baylor College of Medicine. ABOUT TEXAS CHILDREN'S HOSPITAL CENTER FOR VACCINE DEVELOPMENT Texas Children's Hospital Center for Vaccine Development is one of the leading vaccine development centers in the world. Established in Washington DC as the Sabin Vaccine Institute Product Development Partnership (PDP) in the year 2000 and after relocating to the Texas Medical Center in 2011, it rebranded as Texas Children's Center for Vaccine Development. For the past two decades it has acquired an international reputation as a non-profit PDP, advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. In addition, it builds and strengthens capacity for vaccine development locally and with foreign nations and leads global efforts to guide and influence vaccine policy and advocacy through "vaccine diplomacy" as an international bridge for peace and vaccine development capacity. ABOUT BCM VENTURES Baylor College of Medicine Ventures is the commercial engine of the health sciences university, created to support the translation of academic knowledge and intellectual assets for the benefit of society. We do this by engaging university innovators, entrepreneurs and industry to fully develop ideas along their best commercial path. We foster a culture of commercialization and engage with industry to identify market opportunities for collaborative ventures. ABOUT BIOLOGICAL E. LIMITED Biological E. Limited (BE), a Hyderabad-based Pharmaceuticals & Biologics Company founded in 1953, is the first private sector biological products company in India and the first pharmaceutical company in Southern India. BE develops, manufactures and supplies vaccines and therapeutics. BE supplies its vaccines to over 100 countries and its therapeutic products are sold in India and the USA. BE currently has 8 WHO-prequalified vaccines in its portfolio. In recent years, BE has embarked on new initiatives for organisational expansion such as developing generic injectable products for the regulated markets, exploring synthetic biology and metabolic engineering as a means to manufacture APIs sustainably and developing novel vaccines for the global market.

Read More

HEALTH TECHNOLOGY

Nemours Children's Health Chooses the Innovaccer Health Cloud to Support Value-Based Whole-Person Care

Innovaccer Inc. | October 13, 2021

Today Innovaccer Inc., the Health Cloud company, announced a partnership with Nemours Children's Health, one of the nation's largest clinically integrated pediatric health systems, to create a unified data platform designed to accelerate Nemours' mission to transform children's health through a holistic care model. The partnership will integrate and activate clinical and claims data from across the health system to enable intelligent point-of-care analytics that can help identify and close care gaps, optimize management of at-risk lives, and improve clinical outcomes for pediatric patients. Nemours' clinically integrated network (CIN), Delaware Children's Health Network, will leverage the InnovaccerⓇ Health Cloud for clinical and financial insights for 50K+ patients in their network. The Health Cloud's advanced analytics can then use this unified patient data to generate clinical and business insights that support effective cost, utilization, and risk management across the CIN, and across multiple provider and payer contracts. Customizable dashboards will allow the CIN leadership to drill into and understand cost, utilization, risk trends; and digitally transform population risk stratification and health management techniques to identify and address specific population management challenges, match risk with levels of care, individualize treatment plans to lower risk and improve function, and ensure alignment with value-based care models. Indeed, as Nemours Children's Health enters its value-based full-risk contracts they will be using the Innovaccer Health Cloud's intrinsic interoperability and data activation capabilities to integrate payer feeds from both Medicaid and Commercial payers in both the Delaware Valley and Florida—ensuring a 360° actionable view of clinical and financial information. "Our goal is simple—to redefine children's health by helping our communities and families ensure the healthiest futures for our children. By bringing the full richness of our children's healthcare data together, we can better see and understand 'the big picture,' and address all of the factors that influence a child's health. This partnership will help us continue to deliver the safe, high-quality, whole-person care every child deserves." Jonathan Miller, Medical Director for the Nemours Value Based Services Organization About Nemours Children's Health Nemours Children's Health is one of the nation's largest multistate pediatric health systems, including two free-standing children's hospitals and a network of nearly 80 primary and specialty care practices across five states. Nemours mission is "to provide leadership, institutions, and services to restore and improve the health of children through care and programs not readily available, with one high standard of quality and distinction, regardless of the recipient's financial status." Nemours seeks to transform the health of children by adopting a holistic health model that utilizes innovative, safe, and high-quality care, while also caring for the health of the whole child beyond medicine. Nemours also powers the world's most-visited website for information on the health of children and teens, KidsHealth.org. The Nemours Foundation, established through the legacy and philanthropy of Alfred I. duPont, provides pediatric clinical care, research, education, advocacy and prevention programs to the children, families and communities it serves. About Innovaccer Innovaccer Inc., the Health Cloud company, is a leading San Francisco-based healthcare technology company committed to helping healthcare care as one. The Innovaccer Health Cloud unifies patient data across systems and settings, and empowers healthcare organizations to rapidly develop scalable, modern applications that improve clinical, operational, and financial outcomes. Innovaccer's solutions have been deployed across more than 1,000 care settings in the U.S., enabling more than 37,000 providers to transform care delivery and work collaboratively with payers and life sciences companies. Innovaccer has helped organizations integrate medical records for more than 24 million people and generate more than $600 million in savings. Innovaccer is recognized as a Best in KLAS vendor for 2021 in population health management and is the #1 customer-rated vendor by Black Book.

Read More

First rapid detection Zika test now available through collaboration with Texas Children’s Hospital and Houston Methodist Hospital

Texas Children's Hospital | February 23, 2016

Collaboration between two Texas Medical Center institutions has resulted in today’s release of the country’s first hospital-based rapid tests for the Zika virus.Pathologists and clinical laboratory scientists at Texas Children’s Hospital and Houston Methodist Hospital developed the Zika direct test in a matter of weeks as part of the L.E. and Virginia Simmons Collaborative in Virus Detection and Surveillance.

Read More

Events